Target audience: 

Allied Health Care Professionals

Learning objectives: 
  1. Briefly review currently available acute pharmacotherapies
  2. Discuss small molecule calcitonin gene related peptide inhibitors (“gepants”)
  3. Discuss novel selective serotonin 5-HT1F receptor agonist (lasmiditan)



Faculty & credentials: 

Derrick Shumate, DO
Assistant Professor
Department of Neurology
Medical College of Wisconsin


All persons in control of content have NO relevant financial relationships to disclose.


Laura Kurth
Phone number: 
+1 (414) 955-0650

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Session date: 
09/27/2019 - 8:00am to 9:00am CDT
Medical College of WI
8701 Watertown Plank Rd
Health Research Center - Bolger Auditorium #H1400
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.